Articles
COVID-19 Impact on Pharmaceutical Industry Comment
Reflecting on the beginning of the COVID-19 outbreak 12 months ago, it is clear that those pharma companies who responded early to the warning signs – like ChargePoint Technology – were most effective at maintaining business continuity over the...
Articles
Time for a Truly Agile, Global Pharmaceutical Supply chain
Agile supply chains have distinct attributes that help manage vulnerability, disruptions and risk. Recent events demonstrate how valuable an agile process team approach can be to meet new global supply chain realities.
As the COVID-19 pandemic unfolded, there were warning...
Articles
Fill and Finish in Clinical Development: Getting it Right from the Start
Regardless of size, pharma and biotech companies alike encounter numerous challenges in the process of fill and finish of drugs for clinical development, including any subsequent scale-up steps. These challenges encompass the increased complexity of regulatory requirements, processes and...
Articles
The impact of the COVID 19 Pandemic on Global Pharmaceutical Growth
Vaccine production is very complex making specialist expertise vital to ensuring both the safety and efficacy of the final product. Depending on the type of vaccine different approaches are required. For example, a traditional live virus vaccine, which requires...
Articles
Advancements in drug delivery
Advancements in drug delivery for women’s health and beyond
For over two decades, Lubrizol Life Science Health (LLS Health) has been a leader in the field of women’s health, contributing to substantial advancements in the breadth of intravaginal rings and...
Articles
The Impact of COVID-19 on Rare Disease Clinical Trials
Barriers and triumphs of an underserved patient group.
It is undeniable that clinical trials for rare diseases are more challenging to design and execute. Unlike trials with more frequently occurring diseases, rare disease trials have a smaller number of eligible...
Articles
Why pharma should embrace a multi-channel approach
In today’s digital, on-demand world, success means creating new rules of patient engagement that shifts from a single source of truth to personalized, real-time multi-channel interactions.
While pharma companies have realized the importance of developing multichannel strategies, many are just...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.